DENDREON PHARMACEUTICALS LLC

DACS

kit for cell separation consisting primarily of density gradient solutions and a centrifugation tube or a syringe with a modified internal constriction for medical and clinical applications;kit for cell separation consisting primarily of density gradient solutions and a centrifugation tube or a syringe with a modified internal constriction for scientific and research applications;

DENDREON

research and development of pharmaceutical products for others;

DENDREON

pharmaceuticals for use in the treatment of cancer;

DENDREON

Pharmaceuticals for use in the treatment of cancer, infectious and autoimmune diseases;Color is not claimed as a feature of the mark.;

DENDREON

Color is not claimed as a feature of the mark.;Research and development of pharmaceutical products for others;

DENDREON

Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases;

DENDREON

The mark consists of the term Dendreon having a capital D and lowercase endreon in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters e, o, and n, the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the e slightly upward to the right side of the o; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the o slightly upward to the right side of the n, resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part.;Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases;